Plasma-Free Metanephrine and Normetanephrine Quantification for Clinical Applications Validated by Combining Solid-Phase Extraction and HPLC-MS/MS
Molecules · 2025
DOI: 10.3390/molecules30193847 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Hyebin Choi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Korea University Anam Hospital, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: Metanephrine, Solid Phase Extraction, Normetanephrine, Tandem Mass Spectrometry. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, National Research Foundation (NRF) grant funded by the Korean government (MSIT).
Abstract (Originalsprache)
Plasma-free metanephrines are the most sensitive and specific biochemical markers for diagnosing catecholamine-secreting tumors, such as pheochromocytoma and paraganglioma. In this study, we developed and validated a liquid chromatography–tandem mass spectrometry method for quantifying metanephrine and normetanephrine in human plasma, using solid-phase extraction with a weak cation-exchange mechanism. Validation was performed according to the FDA Bioanalytical Method Validation Guidance and CLSI guideline C62-A. The method showed excellent linearity over concentration ranges of 0.11–13.92 nmol/L for metanephrine and 0.14–26.43 nmol/L for normetanephrine, with correlation coefficients exceeding 0.999. The accuracy, precision, and lower limit of quantification met the acceptance criteria of the study. Matrix effect evaluation revealed a process efficiency of 121% for metanephrine at the lowest concentration, slightly exceeding the acceptable range of 100 ± 15%. This was likely because of matrix-induced ion enhancement or variability in extraction efficiency. However, all other tested concentrations were within the acceptable limits. Overall, this method demonstrated high sensitivity, specificity, and reproducibility, making it suitable for routine clinical applications. Minor deviations at low concentrations do not compromise reliability; however, future optimizations, such as matrix-matched calibration, may further improve performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Korea University Anam Hospital, Seoul 02841, Republic of Korea.
ORCID-Profile: Jiwon Yun, Keun Ju Kim, Minjeong Nam, Seung Gyu Yun
Förderung
- National Research Foundation of Korea
- National Research Foundation (NRF) grant funded by the Korean government (MSIT)
Zitieren
APA
Choi, H., Yim, J., Yun, J., Lee, J. K., Kim, K. J., Nam, M., Nam, M. H., Cho, Y., & Yun, S. G. (2025). Plasma-Free Metanephrine and Normetanephrine Quantification for Clinical Applications Validated by Combining Solid-Phase Extraction and HPLC-MS/MS. Molecules. https://doi.org/10.3390/molecules30193847
Vancouver
Choi H, Yim J, Yun J, Lee JK, Kim KJ, Nam M, et al. Plasma-Free Metanephrine and Normetanephrine Quantification for Clinical Applications Validated by Combining Solid-Phase Extraction and HPLC-MS/MS. Molecules. 2025. doi:10.3390/molecules30193847
BibTeX
@article{Choi2025,
author = {Choi, Hyebin and Yim, Jisook and Yun, Jiwon and Lee, Jong Kwon and Kim, Keun Ju and Nam, Minjeong and Nam, Myung Hyun and Cho, Yunjung and Yun, Seung Gyu},
title = {Plasma-Free Metanephrine and Normetanephrine Quantification for Clinical Applications Validated by Combining Solid-Phase Extraction and HPLC-MS/MS},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30193847}
}
EUVIMED